AVR-01

N/A

Report date: 2023/10/26 16:02:13

Base Information

Drug NameAVR-01
Drug Alias NameAVR-01
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionImmunogenetic stimulantsα-Galactosidase replacementsα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvrobio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvrobio
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A